American Academy of Neurology presents 57th Annual Meeting in Miami Beach

March 09, 2005

ST. PAUL, MN (March 9, 2005) - More than 8,000 are expected to attend the American Academy of Neurology's (AAN) 57th Annual Meeting in Miami Beach, April 9 - 16, 2005.

Held in the Miami Beach Convention Center, the very latest research findings on Alzheimer's disease, multiple sclerosis, Parkinson's disease, stroke, migraine, epilepsy, and other neurological disorders will be included in more than 1,300 scientific studies presented as platform and poster sessions. This meeting will also introduce a new magazine and a gala.

Key science presentations will be presented at four plenary sessions, starting with the Presidential Plenary Session on April 12 at 9:00 a.m. The outgoing AAN president Sandra F. Olson, MD, will give the Presidential Lecture on "Women in Neurology." Nobel Prize winner Stanley B. Prusiner, MD, will discuss "Synthetic Prions: Diagnosis and Treatment of Prion Disease." Ira Shoulson, MD, will lecture on "Equipoise and the Value of Uncertainty for Randomized Clinical Trials."

Other plenary sessions will cover Contemporary Clinical Issues and Case Studies (April 13) and Frontiers in Clinical Neuroscience (April 14). The Scientific Program Highlights will conclude the plenary sessions on April 15 beginning at 5:15 p.m. after all educational programs have ended. The chair of the AAN Science Committee, John H. Noseworthy, MD, will moderate a review of the most critical new research presented during this meeting.

The 57th Annual Meeting will mark the launch of new AAN efforts. A reception on April 11 will celebrate the premier issue of Neurology Now, the AAN's forthcoming health magazine for patients and caregivers. On April 13, the AAN Foundation's first Auction Gala: Make Research Happen will raise funds for clinical research fellowships in neurology. The Auction Gala will provide a memorable evening that includes dinner, the chance to bid on several donated items, and a live performance by multi-platinum country music star Clay Walker, who was diagnosed with relapsing-remitting multiple sclerosis in 1996.

For registered journalists, the on-site Press Room will host a variety of media briefings based on research presented during the meeting. The Press Room will also have information on major awards, including the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases and the Public Leadership in Neurology Award.

The American Academy of Neurology, an association of more than 18,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, epilepsy, multiple sclerosis, Parkinson's disease, and stroke.
-end-
For more information about the American Academy of Neurology, visit www.aan.com. The 57th Annual Meeting website is http://am.aan.com.

American Academy of Neurology

Related Multiple Sclerosis Articles from Brightsurf:

New therapy improves treatment for multiple sclerosis
A new therapy that binds a cytokine to a blood protein shows potential in treating multiple sclerosis, and may even prevent it.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

New therapeutic options for multiple sclerosis in sight
Strategies for treating multiple sclerosis have so far focused primarily on T and B cells.

Diet has an impact on the multiple sclerosis disease course
The short-chain fatty acid propionic acid influences the intestine-mediated immune regulation in people with multiple sclerosis (MS).

The gut may be involved in the development of multiple sclerosis
It is incompletely understood which factors in patients with multiple sclerosis act as a trigger for the immune system to attack the brain and spinal cord.

Slowing the progression of multiple sclerosis
Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown.

7T MRI offers new insights into multiple sclerosis
Investigators from Brigham and Women's Hospital have completed a new study using 7 Tesla (7T) MRI -- a far more powerful imaging technology -- to further examine LME in MS patients

How to improve multiple sclerosis therapy
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase.

Vaccinations not a risk factor for multiple sclerosis
Data from over 12,000 multiple sclerosis (MS) patients formed the basis of a study by the Technical University of Munich (TUM) which investigated the population's vaccination behavior in relation to MS.

Read More: Multiple Sclerosis News and Multiple Sclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.